Sequelae and survivorship in patients treated with 131 I-MIBG therapy

Sequelae and survivorship in patients treated with 131 I-MIBG therapy

Show other versions (1)

Background: 131 I-meta-iodobenzylguanidine (131 I-MIBG) has been in therapeutic use since 1980s. Newer treatment modalities are emerging for neuroendocrine tumours (NETs) and chromaffin cell tumours (CCTs), but many of these do not yet have adequate long-term follow-up to determine their longer term...

Full description

Bibliographic Details
Main Authors:	Sze, W, Grossman, AB, Goddard, I, Amendra, D, Shieh, S, Plowman, P, Drake, WM, Akker, SA, Druce, MR
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Sequelae and survivorship in patients treated with (131)I-MIBG therapy.
by: Sze, W, et al.
Published: (2013)

Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
by: Kaltsas, G, et al.
Published: (2003)

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
by: Mukherjee, J, et al.
Published: (2001)

Morbidity in patients on long-term steroid replacement therapy.
by: Druce, MR, et al.
Published: (2010)

Radioterapia interna con metayodobencilguanidina 131I-MIBG
by: Harold Machado, et al.
Published: (2002-07-01)

Neuroendocrine tumors treatment with I-131 Metaiodobenzylguanidine (MIBG)
by: Armaghan Fard-fahani, et al.
Published: (2011-09-01)

تهیّه کیت [I131] متا یُدو بنزیل گوانیدین (MIBG- I131)
by: علی ستاری
Published: (2004-02-01)

131I-MIBG myocardial scintigraphy in patients with Parkinson's disease
by: Tuan-feng YANG, et al.
Published: (2016-06-01)

Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid') tumours of the small bowel.
by: Druce, MR, et al.
Published: (2010)

Cardiac 131I-MIBG scintigraphy in patients with multiple system atrophy
by: Li WANG, et al.
Published: (2014-03-01)

Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors (vol 161, pg 131, 2009)
by: Procopiou, M, et al.
Published: (2009)

Intra-Abdominal Fibrosis in a Modern Cohort of Patients with Mid-Gut Carcinoid Tumors - A Cross-Sectional Survey from One Centre
by: Druce, MR, et al.
Published: (2009)

Intra-abdominal fibrosis in a modern cohort of patients with mid-gut carcinoid tumours - a cross-sectional survey from one centre
by: Druce, MR, et al.
Published: (2009)

Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors (European Journal of Endocrinology 161, 1, (131-140))
by: Procopiou, M, et al.
Published: (2009)

PEMBUATAN SENYAWA BERTANDA 131I-MIBG DENGAN PENINGKATAN DOSIS TERAPI
by: Maskur Maskur, et al.
Published: (2021-02-01)

Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
by: Gupta, P, et al.
Published: (2014)

Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
by: Sen Gupta, P, et al.
Published: (2014)

The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
by: Kaltsas, G, et al.
Published: (2001)

Impact of thyroiditis on 131I uptake during ablative therapy for differentiated thyroid cancer
by: Eugenie S Lim, et al.
Published: (2019-05-01)

I131-MIBG treatment revisited: How important is scheduling when combined with external beam irradiation?
by: Corroyer-Dulmont, A, et al.
Published: (2016)

Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas
by: Nastos, K, et al.
Published: (2017)

Evaluation of 99mTc-HYNIC-TOC and 131I-MIBG imaging in diagnosis of pheochromocytoma and paraganglioma
by: WANG Yu, TONG Anli, ZHOU Yue, ZHANG Wenqian, CUI Yunying, JING Hongli , LI Yuxiu
Published: (2024-03-01)

Familial paraganglioma: a novel presentation of a case and response to therapy with radiolabelled MIBG.
by: Lawrence, J, et al.
Published: (2004)

MIBG scans for phaeochromocytoma: time to abandon the technique?
by: Grossman, A, et al.
Published: (2009)

Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of <sup>131</sup>I-MIBG
by: Ezziddin Samer, et al.
Published: (2012-01-01)

The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.
by: Ali, N, et al.
Published: (2006)

Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
by: Thomas Blom, et al.
Published: (2021-08-01)

131-I-MIBG therapy in combination with PARP inhibitors for young adult patient with relapsed neuroblastoma and DNA repair pathway alterations
by: Sarah Cohen-Gogo, et al.
Published: (2024-06-01)

Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT.
by: Barwick, T, et al.
Published: (2010)

68Ga-DOTATATE PET/CT Compared with 131I-MIBG SPECT/CT in the Evaluation of Neural Crest Tumors
by: Pezhman Shahrokhi, et al.
Published: (2020-01-01)

The effect of exogenous glucocorticoids on plasma catecholamines and metanephrines in patients without phaeochromocytomas.
by: Druce, MR, et al.
Published: (2011)

The Effect of Exogenous Glucocorticoids on Plasma Catecholamines and Metanephrines in Patients Without Phaeochromocytomas
by: Druce, MR, et al.
Published: (2012)

EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours
by: Jonathan Gear, et al.
Published: (2020-03-01)

I-123 imaging for the prediction of I-131 therapy for recurrent differentiated thyroid cancer, RDTC, when I-131 tracer is negative but raised thyroglobulin, Tg
by: Britton, K, et al.
Published: (1999)

The Burden of Survivorship: Survivor Guilt and Its Association with Psychiatric Sequelae in COVID-19 Patients
by: Mariagrazia Palladini, et al.
Published: (2023-04-01)

Multimodality palliative treatment of (111)In-pentetreotide negative/(123)I-MIBG positive metastatic carcinoid - a case report.
by: Dworakowska, D, et al.
Published: (2008)

Improved outcome of 131I-mIBG treatment through combination with external beam radiotherapy in the SK-N-SH mouse model of neuroblastoma
by: Corroyer-Dulmont, A, et al.
Published: (2017)

[177Lu]Lu-DOTA-TATE and [131I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center
by: Stefan Prado-Wohlwend, et al.
Published: (2022-02-01)

Targeted radionuclide therapy for neuroendocrine tumours: principles and application.
by: Druce, MR, et al.
Published: (2010)

123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.
by: Bhatia, K, et al.
Published: (2008)